Skip to main content
Year archive

SAM CHUN DANG PHARM CO. LTD — 2020 filings

All 25 regulatory filings released by SAM CHUN DANG PHARM CO. LTD (000250) in 2020, sourced directly from the official regulator.

25 Filings
2020 Period
2020 filings (25)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-16 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-08-25 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
신주인수권행사
Share Issue/Capital Change
2020-08-10 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-07-22 Korean
전환청구권행사
Share Issue/Capital Change
2020-07-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-07-16 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-14 Korean
투자판단관련주요경영사항(아일리아 바이오시밀러 SCD411 제제 미국 FDA 임상 3상 시험계획 승인)
Regulatory Filings
2020-05-13 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2020-04-07 Korean
사업보고서 (2019.12)
Audit Report / Information FY 2019
2020-03-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-03-26 Korean
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Capital/Financing Update
2020-03-20 Korean
기타경영사항(특허권취득)(자율공시)(안과용 약학 조성물)
Regulatory Filings
2020-03-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-13 Korean
[기재정정]의결권대리행사권유참고서류
AGM Information
2020-02-28 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-02-27 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2020-02-26 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-02-26 Korean
주주총회소집결의
AGM Information
2020-02-18 Korean
기업설명회(IR)개최
Investor Presentation
2020-02-04 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2020-01-20 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2019
2020-01-20 Korean